Bone Marrow Cell Equipment
-
Manufactured by Precision For Medicine, Inc.based in USA
Advancing your research into hematological malignancies, immunology, and other related areas requires access to high quality human bone marrow mononuclear cells. Precision for Medicine has an extensive inventory of normal, healthy donors with longitudinal data and ability to recall for additional biospecimen ...
-
Manufactured by Revmedincbased in SOUTH KOREA
TriCell BMC is a product used to separate bone marrow cell components containing concentrated growth factors through a centrifuge after collecting bone marrow. The safety has been improved through the sealing structure without cell contamination, and foreign substances can be removed ...
-
Manufactured by Charter Medical, LLCbased in USA
Charter Medical’s Advect® Fluid Transfer Sets are designed to support the quality and manufacturing requirements of personalized care. The transfer sets are intended for sterile transfer of bone marrow mononuclear cells from one container to another. ...
-
Manufactured by Hebei Lingding Biotechnology Co., Ltd.based in CHINA
, including a broad spectrum of antibacterial, antiviral and anti-tumor effects, and is related to many important physiological processes in the body, such as regulating the balance of iron in the body, regulating the generation of bone marrow cells, promoting cell growth, regulating the body's immune function, enhancing the ...
-
Manufactured by Biocardia, Inc.based in USA
The investigational CardiAMP™ Cell Therapy is designed to be a comprehensive biotherapeutic heart failure solution, incorporating: a proprietary molecular diagnostic to characterize the potency of a patient’s own bone marrow cells and determine if they are an optimal candidate for therapy. a point of care processing ...
-
Manufactured by LifeTein, LLCbased in USA
Macrophage Colony Stimulating Factor (M-CSF), also known as CSF-1, can be produced by a number of cells, including fibroblasts, monocytes, activated macrophages, secretory epithelial cells of the endometrium, endothelial cells activated by LPS or cytokines, and bone marrow stromal cells. In ...
-
Manufactured by Trailhead Biosystems Inc.based in USA
We are developing human long-term hematopoietic stem cells (LT-HSCs) from human (non-embryo) induced pluripotent stem cells (iPSCs). HSCs are rare subsets of hematopoietic cells that are responsible for the life-long production of all blood cell lineages, and for the reconstitution of bone marrow ...
-
Manufactured by Creative BioMartbased in USA
IL-4 is a pleiotropic cytokine that regulates diverse T and B cell responses including cell proliferation, survival and gene expression. Produced by mast cells, T cells and bone marrow stromal cells, IL-4 regulates the differentiation of naive CD4+ T cells into ...
-
Manufactured by Bone Therapeutics SAbased in BELGIUM
ALLOB is the Company’s off-the-shelf, allogeneic cell therapy platform consisting of human allogeneic bone-forming cells derived from ex-vivo cultured bone marrow mesenchymal stromal cells (MSC) from healthy adult donors, offering numerous advantages in product quality, injectable quantity, ...
-
Manufactured by MDL Srlbased in ITALY
Selective multiradial, micro-aspiration system of autologous bone marrow tissue for stem cell therapy. ...
-
Manufactured by DSMbased in NETHERLANDS
and Bone Marrow Concentrates. LAVA™ cell concentration technology provides the shortest processing times with the smallest and lightest design, consistently delivering high-quality output. High cell concentration and yield with low variability offers more predictable device output. Lightest weight and most portable device ...
-
based in USA
IV-Cell universal culture media is a Research-use only (RUO), ready-to-use, fully supplemented medium developed specifically to support bone marrow and peripheral blood cell culture for in vitro cytogenetic analysis of hematological disease. IV-Cell is a proprietary culture media that does not require the ...
-
based in USA
sulfate in organs and tissues. Very limited and investigational symptomatic treatment options include substrate reduction therapy, enzyme replacement therapy, bone marrow transplantation, stem cell transplantation and gene therapy to address non-CNS symptoms. Gain is developing allosteric regulators that are designed to decrease toxic ...
-
based in USA
in organs and tissues. Very limited and investigational symptomatic treatment options include substrate reduction therapy, enzyme replacement therapy, bone marrow transplantation, stem cell transplantation and gene therapy to address non-CNS symptoms. Gain is developing allosteric regulators that are designed to decrease toxic substrate ...
-
Manufactured by Biocardia, Inc.based in USA
Where the CardiAMP Cell Therapy System uses a patient’s own cells, the CardiALLO system uses culture-expanded, bone marrow-derived mesenchymal stem cells from a universal donor. This allows the cells to be obtained "off the shelf" from a pharmacy, negating the need for a ...
-
Manufactured by Bone Therapeutics SAbased in BELGIUM
Bone Therapeutics is bringing a unique value proposition by developing a range of innovative bone cell therapy products administrable via a minimally invasive technique. ...
-
Distributed by Crescent Chemical Companybased in USA
Crescent Chemical Co., Inc. can supply Ultroser G Serum Substitute. Ultroser Gis manufactured by BioSepra in France. Importation of Ultroser G requires a USDA Importation Permit. Crescent Chemical is happy to help you apply for this ...
-
Manufactured by Alliance Spinebased in USA
Bone Marrow Concentrate System utilizes a proprietary system of gentle centrifugation and protection of the delicate buffycoat layer to produce superior cell yields for Bone Marrow Concentrate ...
-
Manufactured by Novadip Biosciencesbased in BELGIUM
Novadip’s unique “3M3” platform for tissue regeneration combines over 15 years of academic research with practical surgery experience and proof of principle clinical data. ...
-
Manufactured by Rocket Pharmaceuticals, Inc.based in USA
FA is a rare, genetic disorder affecting DNA repair. Approximately two-thirds of FA cases are caused by genetic defects in the FANCA gene, which results in the FA subtype known as FA Complementation Group A (FA-A). FA patients may develop bone marrow failure (very low blood counts), cancers of the blood or other ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you